AQEMIA is a pharmatech company working at the intersection of quantum physics, artificial intelligence, and drug discovery. Its proprietary technology is designed to generate new drug candidates without relying on experimental data, helping researchers explore a broad range of possibilities more quickly. The company operates across healthcare, biotechnology, and AI, offering a focused environment for people interested in computational approaches to pharmaceutical research.
Develop deep-learning and machine-learning models for AQEMIA’s drug discovery platform. Work with chemists and biologists to prioritize compounds and predict molecular properties.